RxDoctor Payments Data

Kayla Meade, APRN

Primary Care · Huntington, WVNPI 1548972508

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,043 of the $2,753 with a category attached, or 74.2%. 10 manufacturers reported payments, led by Saluda Medical Americas, Inc. at 33.0% of the total. 2025 is the largest year on record at $1,423, more than ten times the $13 reported in 2023.

$2,753in general payments, 2019–2025

Across 54 payments — averaging $50.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Saluda Medical Americas, Inc.$909
  • Medtronic$789
  • Boston Scientific$468
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$248
  • Curonix LLC$113
  • Tersera Therapeutics LLC$72
  • plus $153 from 4 others

What the payments were for

  • Travel & lodging$71026%
  • Food & beverage$2,04374%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,753 in reported general payments places this provider in the 85th percentile of 43 primary care providers in West Virginia.

See all primary care providers in West Virginia

Medicare billing

Part B allowed, 2024
$31,308
Medicare patients
134
Services billed
396

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin170$4,354
Gabapentin332$3,929
Buprenorphine17$2,982
Lidocaine46$2,603
Tizanidine Hcl195$1,877
Tramadol Hcl130$1,328
Acetaminophen-CodeineAcetaminophen With Codeine62$1,109
Cyclobenzaprine Hcl79$952
Duloxetine Hcl19$800
Baclofen40$650
Nortriptyline Hcl12$625
Diclofenac Sodium32$545
Methocarbamol29$326
Methenamine Hippurate15$274
Atorvastatin Calcium19$191

Paid to pharmacies, not to this prescriber.

Other primary care in Huntington

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →